Pancreatin-Delayed Release Pellets-Suitable for 10000, 25000, 40000 iu unit Caps (Creon)

  • Release pattern and comparative study done with innovator
  • MKPPL product advantages include:
  • Smaller size of pellets.
  • Spherical shaped pellets compared to the innovator Creon.
  • Higher drug loading possible to meet 50,000 iu lipase activity.

Offer complete technical package for registrations in all regulated/semi regulated markets.

Additional information

70% (Bovine & Porcine), 10000 IU, 25000 IU, 36000IU, 40000IU

Release Type

Delayed Release

Target Formulations


Routes of administration


Documentation Available:

DMF in CTD Format

Forms of PFI

Pellets/Micro pellets (for capsules)

Privacy Preference Center